MontaƱez, Placida V.
HRN: 03-68-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/30/2023
07/07/2023
IV
600mg
Q6
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes